Guest guest Posted October 16, 1999 Report Share Posted October 16, 1999 Enbrel is a biologic and would be digested if taken any other way than injection. Sorry! Quote Link to comment Share on other sites More sharing options...
Guest guest Posted October 24, 1999 Report Share Posted October 24, 1999 How often do you have to inject yourself? once a week as well? --- CTNATIVE@... wrote: > Attention those interested in Enbrel use. First of > all- the question about > Sed rate- sometimes it is called > ESR on the lab report. > > The Enbrel is injected by you after you follow > instructions on mixing it up > fresh at home - twice a week. It is a biologic and > extremely temperature > sensitive- so you need to keep it in the fridge. > You inject it straight in > to minimize the site reaction- in other words- not > on an angle. Many people > have reported an improvement of dramatic proportion > s after just a shot or > two! If it doesn't work at all after a month, my > rheumatologist at Columbia > has found that it won't work period. Virtually no > side effects compared to > other drugs. Some people on it call themselves > Enbrelmaniacs they love it so > much! > > > > ------------------------------------------------------------------------ > Please visit our new web page at: > http://www.wpunj.edu/icip/pa > <HR> <html> > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 3, 1999 Report Share Posted November 3, 1999 Hi Jana, Elliot has been taking Enbrel and I find that it is best to renew it when I have two dose left. It takes our pharmacy 3 days to get it. Also re: insurance- does yours cover the full amount of the drug? Our plan does after $1000 but I had done some research and was surprised to see the varied costs in several local pharmacies. It ranged from $950 to $1300 for a month supply. My pharmacy actually matched the lowest cost. Rena Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 4, 1999 Report Share Posted November 4, 1999 Hi Rena, I picked up our first Enbrel RX yesterday. The actual cost would have been $990.59, I paid $15.00. As far as I can tell, it will be a $15 co-pay each month, which is great news. I will take your advise and refill with 2 doses left. I gave Robbie his 1st shot yesterday at the Rheum. office.... he has been calling me a " loser " ever since because it took me 2 tries to get the needle in. I am sure we will improve with time. I do have a couple of questions. The 1st is dosage. He is getting 25mg x2 a week. In reading, I saw that children usually get .4mg per kg of weight, which would be far less then the 25mg. I called the Seattle Ped. Rheum. this morning. She said she wants him to have the 25mg. Anyone have any information on this? The 2nd question is how far do I have to put the needle in? I put it all the way in yesterday, which ended up in a muscle. Can I just put it part way in? Thanks, Jana Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 4, 1999 Report Share Posted November 4, 1999 In a message dated 11/4/99 12:12:49 PM Pacific Standard Time, JanaB41@... writes: << The 2nd question is how far do I have to put the needle in? I put it all the way in yesterday, which ended up in a muscle. Can I just put it part way in? >> Enbrel is supposed to be a <thinks of how to spell this> sub-cutaneous injection, instead of an intra-muscular like the methotrexate. Something along those lines. You shouldn't have to slide the needle ALL the way in, just far enough to get it under the skin. If it's not in far enough the medication will form a bubble. I don't think that's anything to panic about, but it's a little disturbing to see. <g> cheers Jenni Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 4, 1999 Report Share Posted November 4, 1999 Hi Jana, I see that Charlie posted some old messages but to review- the correct dose is .4mg per kilo. Perhaps more of the doctors are playing with that. Elliot who weighs 35 lbs. is taking 12.5 mg ( which is double the dose) there has been nothing to report home about. When doing clinical trials they randomly assign a dose; I'm sure that as more patients are using enbrel new correct dosages will form. As Jenni explained the injection is subcutaneous. You can get that by keeping the needle at a 45 degree angle. Another thing which we found helpful was using a regular monojet insulin syringe. The syringe supplied is made so that someone with arthritis pain or deformity of the hands could manipulate the syringe easily. The insulin syringe has a thinner needle and it goes in easier. Hope this was helpful. Rena Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 8, 1999 Report Share Posted November 8, 1999 Charlie, Thanks for this information. It is very helpful! Jana Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 8, 1999 Report Share Posted November 8, 1999 Thanks, Rena. Yes, this helps. I won't worry too much about the dose. injected him again yesterday, better then the first time, but I'm sure the needle replacement will help. Thanks, Jana Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 12, 1999 Report Share Posted November 12, 1999 lisbeth, i don't personally know anyone who takes enbrel, but my rheumy is known as an expert in serious RA and he has alot of experience with enbrel and is absolutely delighted with the results. It does appear, from speaking with him, that it has given many of his pts their lives back. Hope this helps. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 30, 1999 Report Share Posted November 30, 1999 a, It is so tempting to try these meds because of all the hype. My gp wanted me to take Celebrex after reading Liz's post today. In the long haul AP will get us there. It is just a longer journey. One after one all these miracle drugs have proven to lose their effectiveness, then they try the next one. The drug companies must be happy if not the poor souls who spend a fortune on these. Bev rheumatic Enbrel > From: a Peden <paula.peden@...> > > I have a little further info from our local AP support meeting last > night that I thought some of you might be interested in. One of the new > ladies reported that she has been part of the Enbrel trials and has been > taking it for 2-1/2 years. She said that at first, she thought it was a > miracle drug because it provided such incredible relief. She said that > as time went on, however, it gradually lost its effectiveness to the > point where now she's not getting great relief from it any more. Her > conclusion was that it seems to operate like many other DMARDs, provides > initial relief but that relief erodes over time. So, she came to our > meeting because she wants to find out about AP and try that. I don't > know about everyone else but every time I hear one of these stories, it > strengthens my resolve that traditional DMARDs, even the new ones, just > are not the wonder drugs that some rheums try to tell us they are. > Hugs, > a Peden > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 30, 1999 Report Share Posted November 30, 1999 a, I tried to edit the post below and it shows how great I am at it. It sounds like my gp is trying to kill me cuz he told me to take Celebrex after reading Liz's post. LOL I took too much off that line. I meant to say, " My gp wanted me to take it and I'm glad I didn't after reading Liz's post " . Hugs Bev Re: rheumatic Enbrel > From: " Briarwood " <briarwood@...> > > a, > It is so tempting to try these meds because of all the hype. My gp wanted > me to take Celebrex after reading Liz's post today. In the long haul AP > will get us there. It is just a longer journey. One after one all these > miracle drugs have proven to lose their effectiveness, then they try the > next one. The drug companies must be happy if not the poor souls who spend > a fortune on these. > > Bev Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 30, 1999 Report Share Posted November 30, 1999 Bev, Sort of figured that's the direction you were headed, it's still hard to prove that the doctors are actually trying to kill us. :} Between Liz and Mark's posts today highlighting that some of the new drugs aren't living up to their publicity, I'm feeling a greater sense of well-being that I don't jump on a new bandwagon until it's been around awhile and all the risks and benefits are known. After all, with the speed that some of these drugs are now being brought to the market, it's not surprising that many of the long term consequences are not coming out until the general public is already using them. I recently heard a Canadian medical show on the radio where both the host doctor and the guest rheumatologist stated that Celebrex was a profound disappointment, with the extra drawback that it doesn't even offer the cardiac benefits that the old nsaids do. Hugs, a Peden Briarwood wrote: > > a, > I tried to edit the post below and it shows how great I am at it. It > sounds like my gp is trying to kill me cuz he told me to take Celebrex after > reading Liz's post. LOL I took too much off that line. I meant to say, > " My gp wanted me to take it and I'm glad I didn't after reading Liz's post " . > Hugs > Bev > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted November 30, 1999 Report Share Posted November 30, 1999 a, But you only spoke to one - I think one could get a better idea by tuning in to alt.support.arthritis and seeing how the folks there are doing with Enbrel. That might broaden the perspective. I personally haven't kept up with its effectiveness, because the cost puts it out of my reach, even if I did like it. I would agree that some of the newer drugs certainly present a risk having not been on the market for long and I would be hesitant to take them unless I was in some pretty dire straits. That said, it is hard to turn aside from a drug like Remicade that shows promise to actually heal bones once they've eroded. But as I understand it, it shares the same problem of Enbrel - eliminating the protein that helps us protect ourselves against infection. If you're not progressing downhill rapidly, it might pay to wait a bit. Everyone's really right in these situations - I don't think anyone is wrong to make a personal decision. Everyone's case is so different and our bodies respond so differently. This whole idea of " I'm right and you're wrong " seems to pervade a lot of the discussion in health support groups and that's sad, if you ask me. And I think it produces incredible amounts of stress, which are beneficial to no one. So I think a that you're right for your decisions and I think is right for the way he feels and I think everyone else is right for how they feel about the issues. I say - let's just get on with getting healthy and keep supporting each other no matter what we decide to do. Hell, I even think Joe's right for fighting those aliens he has swimming around in his body - or was that amoebas? ) LOL Here's to HEALTH BABY! Mark rheumatic Enbrel > From: a Peden <paula.peden@...> > > I think you've misinterpreted what I meant. If you feel you want or > need to try some of the new drugs coming out, then that is completely > your choice and if they work for you, then I say great. I just think > it's important we all know the risks we may be facing along with the > potential benefits so we can clearly decide whether we want to face > those risks. If you then decide to proceed, then I would be the last > person to criticize your choice, just as I would expect to be respected > for my choice not to take them. And while it is difficult to wait for a > potentially good drug to be approved, it is a fact that many of the new > " miracle " drugs have been put on a fast track for approval, with many > side effects not being fully revealed until later. I know my own doctor > was very concerned about how quickly Celebrex was approved and said he > would not prescribe it until it had been on the market for a year > because he wanted to see the true picture of how it performed. I think > the latest reports verify his prudence, however, again, if you want to > try it and its benefits outweigh the negatives for you, then great. I > feel the same about Enbrel. It was something I was also initially > interested in myself but was disappointed to learn that it, too, seems > to have a short lifespan of effectiveness according to first hand > results from someone who is participating in the trials and I felt an > obligation to pass this along to the group. I'm sure you would agree > that it's best to be informed about all the pros and cons when deciding > what treatment to take. I did point out that the trial subject I spoke > to said Enbrel worked great at first for her, the results just didn't > last terribly long. > a Peden > > " W. Matzelle " wrote: > > > > All: > > > > It's funny many of us need something to complain about: either the > > drugs are taking to long to be approved or they are being approved to > > quickly. > > > > Enbrel and other new drugs are attempts to help us, but they are > > expensive because there is much time, work and effort that goes into > > the development of these drugs. Seems like common sense to me...It's > > scary that many are choosing to discount anything that might help > > because it's coming from sources they deem to be suspect. Many > > disease have been cured, and my hope is that RA will bee one of them- > > > > Also, if I can get 2 years of freedom from the pain of RA, I'll take > > it; both for the benefit of feeling like a human being and a the lack > > of wear and tear on my joints. By the way there is no reason you > > can't take AP along with Enbrel from what I understand...Just my > > opinion, as we didn't shut doors to the possibility of AP helping, we > > shouldn't shut the door on the possibility of new drugs being > > developed that can do the same. > > > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 19, 1999 Report Share Posted December 19, 1999 You might want to take a look at alt.support.arthritis or misc.health.arthritis, two Usenet newsgroups on the Internet. I know there are a number of people on Enbrel there, who could answer some of your questions. If you're not sure how to use newsgroups (there's usually a button in your email reader for newsgroups), go to www.deja.com and enter the word Enbrel. You'll get a bunch of listings, many of which will probably be from those newsgroups. For what it's worth, I'm on minocycline and methotrexate and except for some lingering stiffness in my hands (I have RA), my symptoms dramatically improved. However, every single person is different, so my experience may not be your experience (my disclaimer Hope this is of some use! Mark http://Mark_Holmes.tripod.com RA 4/98 AP 7/98 Minocycline (Lederle generic) 100mg 2x/day Daily;Methotrexate (15mg/once weekly); folic acid (1 mg/day); Lodine 400mg 3x/day;Zone Diet;;Fish Oil(9 caps/day);acidopholus;Calcium;Multi-Vit ICQ 18123139 AOL IM - ATHiker95 rheumatic Enbrel Hi, My daughter went to the rheumatologist Friday & they didn't think the methotrexate was doing enough to keep the inflammation down & they want to possibly put her on Enbrel. She is not on AP, but will be willing to discuss trying minocin. She has psoriasis & ankylosing spondilitis. They haven't used Enbrel on her type of arthritis & think it would work good, but have to try & get the insurance to approve it. They are concerned she may get joint damage before they can get the inflammation under control. Has anyone else used this super expensive drug? Has is helped? I could use some advice. It will be the middle of Jan before she can get an appt with the head doctor as he would have to approve it. If it would keep her from getting joint damage we would just have to bear the cost somehow. Debbie McMillan McMillan's Miniatures Conroe, TX http://www.mcmillansminiatures.com email: deb-mc@... Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 20, 1999 Report Share Posted December 20, 1999 A related thought....methotrexate has a greatly increased risk of liver damage in those with Psoriatic Arthritis! (More than RA or other). The ankylosing spondilitis is just another sero-negative arthritis, so she probably has " Psoriatic Arthritis " . PsA is slow to respond to AP, but worth the try! Less side - effects than the major DMARDs or COX-2 inhibitors. -Mike- rheumatic Enbrel Hi, My daughter went to the rheumatologist Friday & they didn't think the methotrexate was doing enough to keep the inflammation down & they want to possibly put her on Enbrel. She is not on AP, but will be willing to discuss trying minocin. She has psoriasis & ankylosing spondilitis. They haven't used Enbrel on her type of arthritis & think it would work good, but have to try & get the insurance to approve it. They are concerned she may get joint damage before they can get the inflammation under control. Has anyone else used this super expensive drug? Has is helped? I could use some advice. It will be the middle of Jan before she can get an appt with the head doctor as he would have to approve it. If it would keep her from getting joint damage we would just have to bear the cost somehow. Debbie McMillan McMillan's Miniatures Conroe, TX http://www.mcmillansminiatures.com <http://www.mcmillansminiatures.com> email: deb-mc@... <mailto:deb-mc@...> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 21, 1999 Report Share Posted December 21, 1999 Do you have numbers of people out of total patient population that are having problems? You are correct that it is not recommended for those who have had septicemia or are prone to infections. However, that is not your average person. How many people out of how many without those problems are falling prey to infections or sepsis? I would be curious to know - Enbrel and Remicade both have that potential problem, but I'm not sure how many people are really being affected, outside of those with the problems you mentioned. Remicade has been shown to be particularly effective in combo with methotrexate in people with refractory arthritis, so I'm not sure it's good to totally condemn these drugs, only because they are not right for a certain subset of people. Mark (always wanna know the numbers - and gotta give my buddy a hard time! - Merry Christmas! rheumatic RA and hormones, RA factor, Enbrel > > Enbrel can and is causing the super infections that were warned against. If you have > ever had septicemia or are prone to infections it could be very dangerous. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 5, 2000 Report Share Posted January 5, 2000 The flare you are experiencing is most likely due to the trauma of the surgeries you went through. I've had the same experience, but eventually I went through surgery with no flareup. This just means you need to double up your efforts - hang in there. Look at diet and detoxification. Ethel shirleyhi@... wrote: > > Happy New Year, everyone. I am rejoining you after being out of the group > for a long time. I had foot surgery and back surgery in the last few months. > I have recently been having a very bad flareup of the RA, and I no longer feel > like the minocin therapy is helping me. As a last resort I have decided to start > Enbrel shots, and had my first one yesterday. I would like to know if anyone > else has tried Enbrel, and what the results were. Is anyone else discouraged > about minocin therapy? I have had RA for six years. I was feeling so well a > few months ago I thought I was in remission, so this latest flare has been ter- > ribly discouraging. Let me hear from you. > Shirley Hillard > > --------------------------- Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 23, 2000 Report Share Posted February 23, 2000 Hi Georgina, I don't remember our exact conversation but I had questioned Elliot's previous Dr. re: enbrel and cancer as you had mentioned once before what your Dr. had said. Elliots Dr. had said there was no increased cancers related to the taking of enbrel in the studies but as it was a new drug the companies put this in their literature more for disclaimer purposes. Many of the patients taking these drugs are immunosuppressed and are at greater risks of getting other problems. Rena Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 23, 2000 Report Share Posted February 23, 2000 Hi Rena, See, it's strange that she would say something like that, without being able to back it up. I think she said she heard about it from a speaker at a conference in San Francisco but I haven't seen anything published about it yet. I'm not sure what exactly they put in their literature. I've read it before but forget. I think I'll go check their website and read it again and see if there's anything pertinent. And I'll ask her about it again tomorrow, when we see her. I do understand that some of the people who may be candidates for it may have a greater risk for other health complications. One of the women I know (with Still's Disease) who was one of the first to use it right after it got approval had to discontinue it. Not too long ago I got a message from her saying that she has a new doctor and he suggested she try it again. I don't really understand where she says that Enbrel treats the symptoms, not the signs. Any ideas? I'll paste in the relevant enbrel stuff, below. Take care, Georgina " ...In spite of my other Rheumy having an entire Enbrel lab in a part of his office, this doctor has worked with Enbrel even longer! He explained to me why I was needlessly taken off Enbrel. As an RN, I felt a bit, well, stupid! Enbrel is now being used for patients with Systemic Vasculitis. I wasn't told that. He feels Systemic Vasculitis is my primary problem with SD being secondary. Interesting. Previously, my ESR began to elevate so I began to flare. My Rheumy took me off Enbrel saying " Obviously it isn't working now. No more. " This Rheumy says he doesn't care about my ESR. (?) Then it dawns on me. (!) Enbrel doesn't stop the progression of the disease. It treats the symptoms, not the signs. {{{{Revelation}}}} I KNEW that. I wanted to kick myself for not questioning it. This guy was able to get a year's Enbrel approved within a month! Talk about action. My insurance changed prescription programs, too. I still have to pay for Enbrel upfront, that's okay. But my co-pay is no longer $300 and doesn't take 3 months (and therefore, $3,300 debt) to get one month paid back. My co-pay is now $110 and I'm paid back prior to the next month's refill! Wowza! It's great. I had a hard time getting back on it. You can't inject with an infection, as I'm sure you must know. I had pneumonia, bronchial pneumonia, a couple of sinus infections, and a few bouts of conjunctivitis. Recovery was slow, but it was nice to stay out of the hospital. I've had 5 injections now. It took 7-8 injections last time, and I'm feeling a bit better. My ESR is 7. My husband says he doesn't believe it, but my doctor says it's nerve pain that is causing me so much pain. Tests usually aren't wrong... " Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 23, 2000 Report Share Posted February 23, 2000 Okay, I got this news release from the Immunex site. It does mention that there were 9 reported cases of cancer, while they had expected 10 based on the numbers of people in the trial. It doesn't say anything more about that, except that the projections came from the National Cancer Institute SEER database. That's out of 641 people (83 people being treated with enbrel for 30 months, 480 being treated for 12 months and 78 being treated for 3 months). So it doesn't sound like that big of a deal. As far as the JRA studies, this one is still pointing to the first trial that looked at 69 children with active polyarticular JRA. ~Georgina ENBREL® (etanercept) Long-Term Clinical Trial Data Presented at the American College of Rheumatology Meeting BOSTON, Nov. 17 /PRNewswire/ -- Data from patients receiving ENBREL® (etanercept) for as long as 41 months were presented at the 63rd National Scientific Meeting of the American College of Rheumatology (ACR) today. The FDA approved ENBREL on November 2, 1998 to treat moderately to severely active rheumatoid arthritis in patients who have an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs). The FDA included children and teen-agers (age 4-17 years) in the ENBREL label when it granted the drug a new indication on May 28, 1999 for the treatment of moderately to severely active polyarticular-course juvenile rheumatoid arthritis patients who have had an inadequate response to one or more DMARDs. Study participants were treated with 25 mg of ENBREL twice weekly and continue to be followed in an ongoing study being conducted in the United States and Canada. Patients described in this presentation had moderate to severely active RA and had failed at least one DMARD. The data presented have not been reviewed by the Food and Drug Administration. Response to ENBREL was sustained over time. Of patients treated for 12 months (n=480), 72, 47 and 21 percent achieved 20, 50 and 70 percent reductions in ACR response criteria, respectively. Of patients treated for 30 months (n=83), 80, 60 and 33 percent achieved 20, 50 and 70 percent reductions in ACR response criteria, respectively. In controlled trials, of patients treated for 3 months (n=78), 62, 41 and 15 percent achieved 20, 50 and 70 percent reductions in ACR response criteria, respectively. No significant differences in rate or type of adverse event were seen when patients continued to receive ENBREL over time. Infections occurred at a rate of 1.55 per patient year compared to 1.82 in controlled clinical trials. Headache occurred at a rate of 0.27 per patient year compared to 0.68 in controlled trials. Serious infections occurred at a rate of 0.050 per patient year compared to 0.043 per patient year in controlled trials. There were nine reports of cancer, similar to the expected number (10.7) calculated from the NCI SEER database. None of the patients has developed a new autoimmune rheumatic disease. IN POSTMARKETING USE, SERIOUS INFECTIONS AND SEPSIS, INCLUDING FATALITIES, HAVE BEEN REPORTED. MANY OF THESE EVENTS OCCURRED IN PATIENTS PREDISPOSED TO INFECTIONS, SUCH AS THOSE WITH ADVANCED OR POORLY CONTROLLED DIABETES. DISCONTINUE ENBREL IN PATIENTS WITH SERIOUS INFECTIONS OR SEPSIS. DO NOT START ENBREL IN THE PRESENCE OF SEPSIS, INFECTION (INCLUDING CHRONIC OR LOCALIZED), OR ALLERGY TO ENBREL OR ITS COMPONENTS. USE CAUTION IN PATIENTS PREDISPOSED TO INFECTION. The most frequent adverse events in adult clinical trials in rheumatoid arthritis (n=349) were injection site reactions (ISR) 37%, infections (35%) and headache (17%). Malignancies were rare (<1%). Only the rate of ISR was higher than placebo. In a JRA study (n=69), infections (62%), headache (19%), abdominal pain (19%), vomiting (13%) and nausea (9%) occurred more frequently than in adults. The types of infections reported in JRA patients were generally mild and consistent with those commonly seen in outpatient pediatric populations. Serious adverse reactions reported rarely were varicella (3%), gastroenteritis (3%), depression/personality disorder (1%), cutaneous ulcer (1%), and esophagitis/gastritis (1%). Immunex (Nasdaq: IMNX) is the manufacturer of ENBREL. Immunex and Wyeth-Ayerst Laboratories market ENBREL in North America. Other Wyeth-Ayerst affiliates will market ENBREL outside of North America. Additional information about ENBREL, including full prescribing information, can be found on the company-sponsored website at (www.enbrel.com) or by calling toll-free 888-4ENBREL (888-436-2735). Immunex is a biopharmaceutical company dedicated to developing immune system science to protect human health. The company's products offer hope to patients with cancer, inflammatory and infectious diseases. American Home Products Corporation's Wyeth-Ayerst division is a major research-oriented pharmaceutical company with leading products in the areas of women's health care, cardiovascular disease therapies, central nervous system drugs, anti-inflammatory agents, vaccines and generic pharmaceuticals. American Home Products owns a majority interest in Immunex. AHP is one of the world's largest research-based pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of prescription drugs and over-the-counter medications. It is also a leader in vaccines, biotechnology, agricultural products and animal health care. This release contains forward-looking statements that involve risks and uncertainties, including risks associated with clinical development, regulatory approvals, patent litigation, product commercialization and other risks described from time to time in the SEC reports filed by Immunex, including the most recently filed 10-K and 10-Q. For more information, please refer to www.immunex.com. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 5, 2000 Report Share Posted April 5, 2000 Hi , In my case my doctor filled out the paper work for my insurance company saying that I am " sero negative " for RA. Your doctor can get approval from your insurance company if he knows what to tell them. In your case , it was that the MTX wasn't working for you. Enbrel hasn't been ok'd yet for PA patients, but should be soon. It's been a great drug for me. Vicki Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 5, 2000 Report Share Posted April 5, 2000 Enbrel is not approved for pa...the ins. co.'s companies do not like to pay the cost---until fda approval Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 10, 2000 Report Share Posted May 10, 2000 Ilena, the potential good news in the near future is that Immunex(maker of enbrel) is in front of the FDA for approval of the drug for pa patients. Hopefully that approval will come before year end and your insurance problems will be a thing of the past. Maybe your rhumy can list your condition as RA for purposes of getting better insurance coverage on enbrel now..Jay Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 10, 2000 Report Share Posted May 10, 2000 Hi, Ilena: The clinical trial I'm taking part in is to create the same " opportunity " for PA folks as for the RA folks. It is not blessed by the FDA for PA yet, and these trials, plus whatever other hoops medications must jump through is part of the reason that I'm among the lucky 12 who are getting either Enbrel or a placebo for 6 months. I have been told that our group will " roll over " into a longitudinal (sp?!) study and Enbrel will be provided without cost as a result of our contributing our bodies for 6 months to help out in the process. I couldn't touch the cost otherwise, either. Maggie Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 10, 2000 Report Share Posted May 10, 2000 Welcome to the group Ilena. You have come to the right place for support and information. I've been a member only a short while and I have learned so much from all these wonderful people. I honestly don't know what I'd do without them now. It is comforting to know that others know what you are talking about. Again, welcome to the group, Donna Medi588520@... wrote: Hello. I am new to this group and I saw a thread on Enbrel. I have been using Enbrel for 1 month with great success. Prior to beginning Enbrel, I had 2 Remicade infusions which brought all symptoms under control very quickly. I am using the Enbrel for maintenance. The problem is the expense. My insurance company will not pay as it is only FDA approved for RA at the moment. I am in the middle of an appeal.Ilena------------------------------------------------------------------------Remember four years of good friends, bad clothes, explosive chemistryexperiments.1/4051/3/_/494167/_/957967520/------------------------------------------------------------------------Please visit our new web page at:http://www.wpunj.edu/icip/paWe are currently discussing new chat times. moderates a chat on arthritis atwww.about.com on Thursday evenings, so check thatout in the meantime! E mail at RA@... for details. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.